Ms. Ruth Field

Ruth is the Market Access Director for AstraZeneca Pharmaceuticals (Pty) Ltd in South Africa. She leads the strategic direction of AstraZeneca’s access strategy for the AstraZeneca portfolio which includes health economics, pricing and reimbursement as well as government affairs.

 

During her extensive (over  25 years) experience in the pharmaceutical industry spanning several high impact positions, Ruth has been instrumental in developing and implementing innovative access solutions, achieving optimal pricing reimbursement, other access conditions as well as securing high level government affairs engagements. She is a recognized and active leader in South Africa’s bio pharmaceutical industry serving as the AstraZeneca South Africa representative with government officials, industry trade associations, think tanks and influential policy organizations.

 

She previously worked for Novartis, Abbott, Eli Lilly and Merck where she was responsible for Sub Saharan Africa (including South Africa); East Africa; Lusophone countries. (Angola and Mozambique)

 

She served as a trustee on the board of Love Life in 2018. She is a board member at the Nordic South African Business Association (NSBA). She is also a board Member at the National  Stokvel Association of South Africa (NASASA). She supports Stanza Bopape Drop in Centre for children  in Mamelodi and is currently a shareholder and board member at Labotec Holdings South Africa.